Table of Content


Executive Summary
Industry Outlook
Industry Overview
Industry Trends
Market Snapshot
Market Definition
Market Outlook
PEST Analysis
Porter Five Forces
Related Markets
Market characteristics
Market Evolution
Market Trends and Impact
Advantages/Disadvantages of Market
Regulatory Impact
Market Offerings
Market Segmentation
Market Dynamics
Drivers
Restraints
Opportunities
DRO - Impact Analysis
Indication: Market Size & Analysis
Overview
Autoimmune Disease
Blood Disorders
Infectious Disease
Chronic Disorder
Oncology
Offsite Treatment
Other Diseases
Type of Manufacturing: Market Size & Analysis
Overview
In-House Manufacturing
Contract Manufacturing
Product: Market Size & Analysis
Overview
Insulin
Recombinant human growth hormone (rhGH)
Granulocyte colony-stimulating factor
Interferon
Erythropoietin
Etanercept
Monoclonal antibodies
Rituximab
Infliximab
Adalimumab
Trastuzumab
Follitropin
Glucagon
Calcitonin
Teriparatide
Enoxaparin Sodium
Geography: Market Size & Analysis
Overview
North America
Europe
Asia Pacific
Rest of the World
Competitive Landscape
Competitor Comparison Analysis
Market Developments
Mergers and Acquisitions, Legal, Awards, Partnerships
Product Launches and execution
Vendor Profiles
Dr. Reddy’s Laboratories
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Stada Arzneimittel Ag
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Coherus Biosciences
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Biocad
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Amega Biotech
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Probiomed
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Boehringer Ingelheim
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Apotex
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Fresenius Kabi
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Gedeon Richter
Overview
Product Offerings
Geographic Revenue
Business Units
Developments
SWOT Analysis
Business Strategy
Companies to Watch
Mabxience
Overview
Market
Business Strategy
Sandoz
Overview
Market
Business Strategy
Pfizer
Overview
Market
Business Strategy
Eli Lilly
Overview
Market
Business Strategy
Teva Pharmaceutical
Overview
Market
Business Strategy
Celltrion
Overview
Market
Business Strategy
Biocon
Overview
Market
Business Strategy
Amgen
Overview
Market
Business Strategy
Samsung Biologics
Overview
Market
Business Strategy
Mylan
Overview
Market
Business Strategy
Analyst Opinion
Annexure
Report Scope
Market Definitions
Research Methodology
Data Collation and In-house Estimation
Market Triangulation
Forecasting
Report Assumptions
Declarations
Stakeholders
Abbreviations



List of Figures


Charts
GLOBAL BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR AUTOIMMUNE DISEASE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR BLOOD DISORDERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR INFECTIOUS DISEASE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR CHRONIC DISORDER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR OFFSITE TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR OTHER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR IN-HOUSE MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR CONTRACT MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR INSULIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR RHGH, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR GRANULOCYTE COLONY STIMULATING FACTOR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR INTERFERON, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ERYTHROPOIETIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ETANERCEPT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR FOLLITROPIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR GLUCAGON, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR CALCITONIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR TERIPARATIDE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ENOXAPARIN SODIUM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)


List of Tables


Tables
GLOBAL BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR AUTOIMMUNE DISEASE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR BLOOD DISORDERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR INFECTIOUS DISEASE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR CHRONIC DISORDER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR OFFSITE TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR OTHER, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR IN-HOUSE MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR CONTRACT MANUFACTURING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR INSULIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR RHGH, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR GRANULOCYTE COLONY STIMULATING FACTOR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR INTERFERON, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ERYTHROPOIETIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ETANERCEPT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR FOLLITROPIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR GLUCAGON, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR CALCITONIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR TERIPARATIDE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
GLOBAL BIOSIMILARS MARKET VALUE FOR ENOXAPARIN SODIUM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
NORTH AMERICA BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
EUROPE BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
ASIA PACIFIC BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY INDICATION, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY TYPE OF MANUFACTURING, 2020-2026 (USD BILLION)
REST OF WORLD BIOSIMILARS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
DR. REDDY’S LABORATORIES: OVERVIEW
DR. REDDY’S LABORATORIES: STRATEGIC SNAPSHOT
DR. REDDY’S LABORATORIES: BUSINESS FOCUS
DR. REDDY’S LABORATORIES: PRODUCT/SERVICE PORTFOLIO
STADA ARZNEIMITTEL AG: OVERVIEW
STADA ARZNEIMITTEL AG: STRATEGIC SNAPSHOT
STADA ARZNEIMITTEL AG: BUSINESS FOCUS
STADA ARZNEIMITTEL AG: PRODUCT/SERVICE PORTFOLIO
COHERUS BIOSCIENCES: OVERVIEW
COHERUS BIOSCIENCES: STRATEGIC SNAPSHOT
COHERUS BIOSCIENCES: BUSINESS FOCUS
COHERUS BIOSCIENCES: PRODUCT/SERVICE PORTFOLIO
BIOCAD: OVERVIEW
BIOCAD: STRATEGIC SNAPSHOT
BIOCAD: BUSINESS FOCUS
BIOCAD: PRODUCT/SERVICE PORTFOLIO
AMEGA BIOTECH: OVERVIEW
AMEGA BIOTECH: STRATEGIC SNAPSHOT
AMEGA BIOTECH: BUSINESS FOCUS
AMEGA BIOTECH: PRODUCT/SERVICE PORTFOLIO
PROBIOMED: OVERVIEW
PROBIOMED: STRATEGIC SNAPSHOT
PROBIOMED: BUSINESS FOCUS
PROBIOMED: PRODUCT/SERVICE PORTFOLIO
BOEHRINGER INGELHEIM: OVERVIEW
BOEHRINGER INGELHEIM: STRATEGIC SNAPSHOT
BOEHRINGER INGELHEIM: BUSINESS FOCUS
BOEHRINGER INGELHEIM: PRODUCT/SERVICE PORTFOLIO
APOTEX: OVERVIEW
APOTEX: STRATEGIC SNAPSHOT
APOTEX: BUSINESS FOCUS
APOTEX: PRODUCT/SERVICE PORTFOLIO
FRESENIUS KABI: OVERVIEW
FRESENIUS KABI: STRATEGIC SNAPSHOT
FRESENIUS KABI: BUSINESS FOCUS
FRESENIUS KABI: PRODUCT/SERVICE PORTFOLIO
GEDEON RICHTER: OVERVIEW
GEDEON RICHTER: STRATEGIC SNAPSHOT
GEDEON RICHTER: BUSINESS FOCUS
GEDEON RICHTER: PRODUCT/SERVICE PORTFOLIO